395 related articles for article (PubMed ID: 12925385)
1. Permethrin-resistant human head lice, Pediculus capitis, and their treatment.
Yoon KS; Gao JR; Lee SH; Clark JM; Brown L; Taplin D
Arch Dermatol; 2003 Aug; 139(8):994-1000. PubMed ID: 12925385
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice.
Meinking TL; Vicaria M; Eyerdam DH; Villar ME; Reyna S; Suarez G
Pediatr Dermatol; 2004; 21(6):670-4. PubMed ID: 15575855
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States.
Meinking TL; Serrano L; Hard B; Entzel P; Lemard G; Rivera E; Villar ME
Arch Dermatol; 2002 Feb; 138(2):220-4. PubMed ID: 11843643
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of treatments for pediculosis capitis infestations: update 2000.
Meinking TL; Entzel P; Villar ME; Vicaria M; Lemard GA; Porcelain SL
Arch Dermatol; 2001 Mar; 137(3):287-92. PubMed ID: 11255326
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant lice.
Elston DM
Arch Dermatol; 2003 Aug; 139(8):1061-4. PubMed ID: 12925396
[No Abstract] [Full Text] [Related]
6. A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Crème Rinse (1% permethrin) used as labeled, for the treatment of head lice.
Meinking TL; Vicaria M; Eyerdam DH; Villar ME; Reyna S; Suarez G
Pediatr Dermatol; 2007; 24(4):405-11. PubMed ID: 17845167
[TBL] [Abstract][Full Text] [Related]
7. Permethrin and malathion resistance in head lice: results of ex vivo and molecular assays.
Bouvresse S; Berdjane Z; Durand R; Bouscaillou J; Izri A; Chosidow O
J Am Acad Dermatol; 2012 Dec; 67(6):1143-50. PubMed ID: 22627039
[TBL] [Abstract][Full Text] [Related]
8. Survey of permethrin and malathion resistance in human head lice populations from Denmark.
Kristensen M; Knorr M; Rasmussen AM; Jespersen JB
J Med Entomol; 2006 May; 43(3):533-8. PubMed ID: 16739412
[TBL] [Abstract][Full Text] [Related]
9. Head lice.
Burgess I
Clin Evid; 2005 Dec; (14):2044-9. PubMed ID: 16620480
[No Abstract] [Full Text] [Related]
10. Widespread insecticide resistance in head lice to the over-the-counter pediculocides in England, and the emergence of carbaryl resistance.
Downs AM; Stafford KA; Hunt LP; Ravenscroft JC; Coles GC
Br J Dermatol; 2002 Jan; 146(1):88-93. PubMed ID: 11841371
[TBL] [Abstract][Full Text] [Related]
11. Evidence for double resistance to permethrin and malathion in head lice.
Downs AM; Stafford KA; Harvey I; Coles GC
Br J Dermatol; 1999 Sep; 141(3):508-11. PubMed ID: 10583056
[TBL] [Abstract][Full Text] [Related]
12. Head lice treatments: Searching for the path of least resistance.
Heymann WR
J Am Acad Dermatol; 2009 Aug; 61(2):323-4. PubMed ID: 19615542
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediculosis capitis infested children with 1% permethrin shampoo in Turkey.
Yazar S; Sahin I
Ethiop Med J; 2005 Oct; 43(4):279-83. PubMed ID: 16523649
[TBL] [Abstract][Full Text] [Related]
14. Advancements in the treatment of head lice in pediatrics.
Eisenhower C; Farrington EA
J Pediatr Health Care; 2012; 26(6):451-61; quiz 462-4. PubMed ID: 23099312
[TBL] [Abstract][Full Text] [Related]
15. Oral ivermectin versus malathion lotion for difficult-to-treat head lice.
Chosidow O; Giraudeau B; Cottrell J; Izri A; Hofmann R; Mann SG; Burgess I
N Engl J Med; 2010 Mar; 362(10):896-905. PubMed ID: 20220184
[TBL] [Abstract][Full Text] [Related]
16. Head lice treatments and school policies in the US in an era of emerging resistance: a cost-effectiveness analysis.
Gur I; Schneeweiss R
Pharmacoeconomics; 2009; 27(9):725-34. PubMed ID: 19757866
[TBL] [Abstract][Full Text] [Related]
17. Therapy for head lice based on life cycle, resistance, and safety considerations.
Lebwohl M; Clark L; Levitt J
Pediatrics; 2007 May; 119(5):965-74. PubMed ID: 17473098
[TBL] [Abstract][Full Text] [Related]
18. Malathion for head lice and scabies: treatment and safety considerations.
Idriss S; Levitt J
J Drugs Dermatol; 2009 Aug; 8(8):715-20. PubMed ID: 19663108
[TBL] [Abstract][Full Text] [Related]
19. Pesticide resistant head lice. Interview by Jennifer Ford.
Nealon M; Findlay J
Adv Nurse Pract; 2008 Aug; 16(8):53-5. PubMed ID: 19181178
[No Abstract] [Full Text] [Related]
20. Differential permethrin susceptibility of head lice sampled in the United States and Borneo.
Pollack RJ; Kiszewski A; Armstrong P; Hahn C; Wolfe N; Rahman HA; Laserson K; Telford SR; Spielman A
Arch Pediatr Adolesc Med; 1999 Sep; 153(9):969-73. PubMed ID: 10482215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
